-PTI NEW DELHI: Prices of over 50 essential Drugs including those used for treatment of HIV infection, diabetes, anxiety disorders, bacterial infections, angina and acid reflux have been capped by the government, leading to a price cut in the range of 5 per cent to 44 per cent. The National Drug Pricing Regulator has also fixed the retail prices of 29 formulations. "NPPA has fixed/revised ceiling prices of 55 scheduled formulations of Schedule-I...

-The Indian Express Manmohan Singh also suggested that the panel — which is looking into the demonetisation decision — call government officials to depose before it hears RBI Governor Urjit Patel. New Delhi: During a meeting of the Parliamentary Committee on Finance on Thursday, former Prime Minister Manmohan Singh sought to know whether the RBI was given sufficient time to hold deliberations on the government’s demonetisation move. He also suggested that the...

-The Telegraph New Delhi: The Centre has decided to write to all state governments asking them to launch a crackdown on outdoor advertisements of traditional medicines that claim to "magically" cure various illnesses and cosmetic problems. Sources in the Union information and broadcasting ministry said the letters will be sent out following a nudge from the Union ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy. The Ayush ministry, a few months...

-The Telegraph New Delhi: A health consortium today questioned a decision by Delhi High Court earlier this week to quash the Centre's ban on 344 cocktails of two or more medicines and urged doctors across the country to stop prescribing them. The Jan Swasthya Abhiyan (JSA), the Indian section of the global People's Health Movement, said it was shocked at the judgment because there was "no scientific rationale" for the continued use...

-The Hindu The proposal to extend the time limit for State-level drug regulatory approvals from four to 10 years could hit the generics market In a scathing letter to the Government of India, the Indian Pharmaceutical Alliance (IPA) took issue with what it considered to be a backdoor extension for data exclusivity norms in the country. It pointed to the recent government proposal to change the four-year time limit for State-level drug...